Article 141(1) procedure: Selective treatment during the dry period per quadrant of mammary gland

It is recalled that the Marketing Authorisation Holders' duty, in accordance with Article 58(4) of Regulation (EU) 2019/6, is to ensure that the summary of product characteristics, the package leaflet and the labelling are regularly updated in the light of current scientific knowledge.

Please refer to the website  //www.hma.eu/veterinary-medicines/cmdv/advice-from-cmdv.html